Sodium-Glucose Cotransporter 2 Inhibitor Treatment and Risk of Atrial Fibrillation: Scandinavian Cohort Study.

Arvid EngströmViktor WintzellMads MelbyeAnders HviidBjörn EliassonSoffia GudbjörnsdottirKristian HveemChristian JonassonHenrik SvanströmBjörn PasternakPeter Ueda

Published in: Diabetes care (2023)

In this cohort study using nationwide data from three countries, use of SGLT2 inhibitors, compared with GLP-1 receptor agonists, was associated with a modestly reduced risk of new-onset AF.

Keyphrases

atrial fibrillation
heart failure
oral anticoagulants
left atrial
catheter ablation
left atrial appendage
big data
direct oral anticoagulants
percutaneous coronary intervention
combination therapy
machine learning
mitral valve
replacement therapy
venous thromboembolism